Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank.
Emmy BorgmästarsSara JacobsonMaja SimmMattias JohanssonOla BillingChristina LundinHanna NyströmDaniel ÖhlundZelmina Lubovac-PilavPär JonssonOskar FranklinMalin SundPublished in: Journal of gastrointestinal oncology (2024)
Indoleacetate, 3-hydroxydecanoate (10:0-OH), and RI: 2,745.4 were identified as the top candidate biomarkers for early detection. However, continued efforts are warranted to determine the usefulness of these metabolites as early pancreatic cancer biomarkers.